Finanzwire Finanzwire
Basculer en Français
10215 Companies
210520 Keywords
140513 Articles
111551 Press releases
Headlines Articles Press releases Norgine Remove
  1. Home
  2. Companies
  3. Norgine
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/26/2026 at 07:10, 20 days 1 hour ago

    Swissmedic Approves PEDMARQSI® for Preventing Hearing Loss in Children

    Swissmedic Approval Norgine PEDMARQSI® Children's Hearing Loss Cisplatin Chemotherapy
  • PRESS RELEASE

    published on 03/26/2026 at 07:05, 20 days 1 hour ago

    Norgine announces Swissmedic approval of PEDMARQSI® for the prevention of cisplatin induced hearing loss in children

    Norgine announces Swissmedic approval of PEDMARQSI(R) for the prevention of cisplatin induced hearing loss in children. PEDMARQSI(R) becomes the first treatment in Switzerland for this medical need
    Children Swissmedic Approval Norgine PEDMARQSI Cisplatin Induced Hearing Loss
    Logo of Norgine
  • BRIEF

    published on 02/27/2026 at 13:10, 1 month 15 days ago

    Norgine Awaits European Commission's Decision on Mavorixafor for WHIM Syndrome

    European Commission CHMP Opinion Norgine Mavorixafor WHIM Syndrome
  • PRESS RELEASE

    published on 02/27/2026 at 13:05, 1 month 15 days ago

    Norgine welcomes positive CHMP opinion recommending approval of mavorixafor in the European Union for WHIM syndrome

    Norgine's mavorixafor receives positive CHMP opinion for WHIM syndrome treatment in the EU. Final EC decision expected in Q2 2026. Partnership with X4 Pharmaceuticals
    CHMP Opinion Norgine Mavorixafor WHIM Syndrome X4 Pharmaceuticals
    Logo of Norgine
Accesswire
  • Published on 04/15/2026 at 08:05, 18 minutes ago

    Tocvan Mobilizes Heavy Equipment at Gran Pilar to Accelerate Trenching and Mine Works

  • Published on 04/15/2026 at 05:15, 3 hours 8 minutes ago

    Northern Dynasty: Plaintiffs File Response Briefs Detailing Serious Issues in DOJ Brief

  • Published on 04/15/2026 at 01:40, 6 hours 43 minutes ago

    Presentation to SMI Panama Conference

  • Published on 04/15/2026 at 00:00, 8 hours 23 minutes ago

    GECC Reports F2026 Q2 Financial Results

  • Published on 04/14/2026 at 23:00, 9 hours 23 minutes ago

    Inventus Announces Non-Brokered $2.0 Million Flow-Through Financing With $1.0 Million Lead Order

View all ACCESSWIRE
EQS Group
  • Published on 04/15/2026 at 08:15, 8 minutes ago

    Advancing a New Standard for Neonatal Training Across Europe: European Master Programme in Neonatology Officially Certified

  • Published on 04/15/2026 at 08:15, 8 minutes ago

    LUX CHIN UP: The Free and Easy Fix for Text Neck Syndrome

  • Published on 04/15/2026 at 08:05, 18 minutes ago

    Cainiao Debuts ZeeBot Climbing Robot, Doubling Storage & Retrieval Productivity in Live Operations

  • Published on 04/15/2026 at 08:00, 23 minutes ago

    Zentra Group plc: Director/PDMR Transaction

  • Published on 04/15/2026 at 08:00, 23 minutes ago

    Eleving Group issues EUR 134.41 million worth of loans in the first quarter of 2026

View all EQS
Les Echos
  • Published on 04/15/2026 at 07:30, 53 minutes ago

    Covivio Hotels - Revenues at end-March 2026 : +1.4% Revenue growth year-on-year

  • Published on 04/15/2026 at 07:30, 53 minutes ago

    Covivio is accelerating its expansion in the hotel sector with the acquisition of four hotels in Milan for €217 million

  • Published on 04/14/2026 at 18:24, 13 hours 59 minutes ago

    Covivio Hotels - Descriptif du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte des actionnaires du 14 avril 2026

  • Published on 04/14/2026 at 18:00, 14 hours 23 minutes ago

    2025 annual results

  • Published on 04/14/2026 at 17:40, 14 hours 43 minutes ago

    Collaboration between Terra Innovatum and Mersen

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy